2021 News Conference: Panelist Bios

Rochelle P. Walensky, MD, MPH

Laura E. Riley, MD

Cedric “Jamie” Rutland, MD

William Schaffner, MD

Patricia A. Stinchfield, RN, MS, CPNP


Rochelle P. Walensky, MD, MPH

Rochelle P. Walensky, MD, MPH, is the 19th director of the Centers for Disease Control and Prevention (CDC) and the ninth administrator of the Agency for Toxic Substances and Disease Registry. She is an influential scholar whose pioneering research has helped advance the national and global response to HIV/AIDS. Dr. Walensky is also a well-respected expert on the value of testing and treatment of deadly viruses.

Dr. Walensky served as chief of the Division of Infectious Diseases at Massachusetts General Hospital from 2017 to 2020 and professor of medicine at Harvard Medical School from 2012 to 2020. She served on the frontline of the COVID-19 pandemic and conducted research on vaccine delivery and strategies to reach underserved communities. Dr. Walensky is recognized internationally for her work to improve HIV screening and care in South Africa and is nationally recognized for motivating health policy and informing clinical trial design and evaluation in a variety of settings. She is a past chair of the Office of AIDS Research Advisory Council at the National Institutes of Health and previously served as an advisor to both the World Health Organization and the Joint United Nations Program on HIV/AIDS. Originally from Maryland, Dr. Walensky received her Bachelor of Arts from Washington University in St. Louis, her Doctor of Medicine from the Johns Hopkins School of Medicine, and her Masters in Public Health from the Harvard School of Public Health.


Laura E. Riley, MD

Laura E. Riley, MD is a renowned obstetrician and maternal-fetal medicine specialist. She is obstetrician and gynecologist-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center and chair of the Department of Obstetrics and Gynecology at Weill Cornell Medicine. She leads the state-of-the-art NewYork-Presbyterian Alexandra Cohen Hospital for Women and Newborns and oversees obstetrics and gynecology at NewYork-Presbyterian/ Weill Cornell, NewYork-Presbyterian Lower Manhattan Hospital, NewYork-Presbyterian Brooklyn Methodist Hospital, and NewYorkPresbyterian Queens.

Before joining NewYork-Presbyterian, she served as vice chair of Obstetrics and medical director of Labor and Delivery at Massachusetts General Hospital. An internationally recognized expert on obstetric infectious diseases, she has worked with the Centers for Disease Control and Prevention and other agencies to develop practice guidelines for pregnancy care of women with Group B strep, Zika, Ebola, COVID-19, and influenza viruses.


Cedric “Jamie” Rutland, MD

Cedric “Jamie” Rutland, MD, is a triple board-certified Pulmonary, Critical Care, and Internal Medicine physician and owner of Rutland Medical Group, a private practice in Newport Beach, CA. Dr. Rutland is also owner of Medicine Deconstructed Productions, a company that produces medical education for healthcare companies and the general population. He serves as vice president for the nonprofit organization, AHSM, whose mission is to preserve the integrity of online medical information and also serves as the COVID-19 medical director for Private Health Management. In addition, Dr. Rutland is a national spokesperson for the American Lung Association. He served on the frontline of the COVID-19 pandemic and has become an expert in SARS-CoV-2 and post COVID symptoms. He is a leading medical influencer on social media and an internationally recognized speaker and educator.

Prior to forming his own companies, Dr. Rutland completed his Bachelor of Science from the UC Davis School of Medicine and Internal Medicine residency from the University of Iowa Carver College of Medicine and completed his fellowship in Pulmonary and Critical Care from the University of Kansas Medical Center. He is also an expert in asthma, chronic obstructive pulmonary disease, interstitial lung disease, endobronchial ultrasound, navigational bronchoscopy, and vaping-related lung injury.


William Schaffner, MD (Moderator)

William Schaffner, MD, is medical director of the National Foundation for Infectious Diseases (NFID). Dr. Schaffner currently serves as NFID liaison to the Advisory Committee on Immunization Practices (ACIP) at the Centers for Disease Control and Prevention (CDC).

He is past-president of NFID and is a member of numerous other professional societies. Dr. Schaffner is active in the field of infectious disease research and has authored or co-authored more than 400 published studies, reviews, and book chapters. He currently serves on the editorial board of The Journal of Infectious Diseases, Vaccine, and the CDC Morbidity and Mortality Weekly Report. He is also a featured guest author for Infectious Disease News.

His work has focused on all aspects of infectious diseases including epidemiology, infection control, and immunization. He has received many national awards for his work, including the inaugural 2017 National Vaccine Program Office UpShot Award for excellence in vaccine communication; the 2013 John P. Utz Leadership Award from NFID for his longstanding service to the organization and the field of infectious diseases; and the 2009 James D. Bruce Award from the American College of Physicians for distinguished contributions to preventive medicine. Dr. Schaffner is a professor of preventive medicine and infectious diseases at Vanderbilt University School of Medicine and he has worked extensively on the effective use of vaccines in adult populations.


Patricia A. Stinchfield, RN, MS, CPNP

Patricia (Patsy) A. Stinchfield, RN, MS, CPNP is president-elect of the National Foundation for Infectious Diseases (NFID). Throughout her 45-year nursing career, she has focused on infectious disease prevention. She is a frequent national speaker on vaccine hesitancy, vaccinology, and vaccination of healthcare professionals. A pediatric nurse practitioner specializing in vaccine-preventable diseases, she currently has an affiliate faculty position in the School of Nursing at the University of Minnesota. Prior to her retirement in July 2021, she served as senior director of infection prevention and control at Children’s Minnesota, where she remains on professional staff.

Stinchfield is a widely recognized infectious diseases specialist, having served as the first nurse voting member of the Advisory Committee on Immunization Practices (ACIP) where she continues to serve as a liaison member for the National Association of Pediatric Nurse Practitioners and serves on the Influenza and Schedule Work Groups. She was the hospital incident commander for the COVID-19 response at Children’s Minnesota, and led the responses during the H1N1 influenza and the 2017 measles outbreaks. Stinchfield was lead author of a 2020 NFID report on Vitamin A for the Management of Measles in the US. She was instrumental in increasing the staff voluntary flu vaccination rate at Children’s Minnesota to 94 percent and sustained that over several seasons.

 

 

Learn more at www.nfid.org/2021flunews